Skip to content
10-K

Annual Report

ACUTUS MEDICAL, INC.

0001628280-24-014036

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 25, 2024 29.72M sh
Stock Repurchased FY 2023 · Dec 31, 2023 $0
Stock Repurchased FY 2023 · Dec 31, 2022 $111K
Shares Diluted restated FY 2023 · Dec 31, 2022 37.15M sh
Capex restated FY 2023 · Dec 31, 2022 $228K
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$88.92M
Long Term Debt FY 2023 · Dec 31, 2022 $34.43M
Short Term Debt FY 2023 · Dec 31, 2022 $0
Cash And Equivalents FY 2023 · Dec 31, 2022 $25.58M
Current Liabilities FY 2023 · Dec 31, 2022 $19.87M
Total Liabilities FY 2023 · Dec 31, 2022 $58.42M
Current Assets FY 2023 · Dec 31, 2022 $117.87M
Total Assets FY 2023 · Dec 31, 2022 $133.44M
Eps Diluted FY 2023 · Dec 31, 2022 −$1.40
Eps Basic FY 2023 · Dec 31, 2022 −$1.40
Sga Expense restated FY 2023 · Dec 31, 2022 $20.32M
Rd Expense restated FY 2023 · Dec 31, 2022 $3.12M
Net Income FY 2023 · Dec 31, 2022 −$39.62M
Operating Income restated FY 2023 · Dec 31, 2022 $41.04M
Gross Profit FY 2023 · Dec 31, 2022 −$1.91M
Cost Of Revenue restated FY 2023 · Dec 31, 2022 $4.94M
Revenue restated FY 2023 · Dec 31, 2022 $3.03M
Stockholders Equity FY 2023 · Dec 31, 2021 $105.73M